Treatment of Malignant Carcinoid Tumors With Recombinant Interferon alfa-2b: Development of Neutralizing Interferon Antibodies and Possible Loss of Antitumor Activity

Verfasser / Beitragende:
[K. Öberg, G. Alm, A. Magnusson, G. Lundqvist, E. Theodorsson, L. Wide, E. Wilander]
Ort, Verlag, Jahr:
1989
Enthalten in:
JNCI: Journal of the National Cancer Institute, 81/7(1989-04-05), 531-535
Format:
Artikel (online)
ID: 396001416